We are live on ! Find out more
TMC

Trellus Management Company Portfolio holdings

AUM $72.8M
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+8.21%
1 Year Est. Return
+4.5%
3 Year Est. Return
+267.94%
5 Year Est. Return
+673.14%
10 Year Est. Return
+719.68%
AUM
$193M
AUM Growth
+$71.9M
Cap. Flow
+$6.35M
Cap. Flow %
3.29%
Top 10 Hldgs %
67.5%
Holding
83
New
30
Increased
6
Reduced
8
Closed
20

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.73%
2 Technology 15.99%
3 Consumer Discretionary 7.84%
4 Financials 4.55%
5 Healthcare 4.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UGL icon
76
ProShares Ultra Gold
UGL
$844M
-20,800
Closed -$355K
CTT
77
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
-10,976
Closed -$103K
TLMD
78
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
-110,400
Closed -$866K
CLDR
79
DELISTED
Cloudera, Inc.
CLDR
-40,000
Closed -$556K
WIFI
80
DELISTED
Boingo Wireless, Inc.
WIFI
-112,800
Closed -$1.44M
PRGX
81
DELISTED
PRGX Global, Inc.
PRGX
-136,801
Closed -$1.04M
BHVN
82
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-20,000
Closed -$1.71M
BHVN
83
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-9,600
Closed -$823K

Similar funds

Trellus Management Company's Q1 2021 Portfolio in Review

As of Q1 2021, Trellus Management Company held 83 positions worth $193M, up 59% from $121M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Trellus Management Company deployed $6.35M of net new capital in Q1 2021, opening 30 new positions and adding to 6 existing holdings. Its largest new stake was dMY Technology Group, Inc. II: 250,000 shares worth $3.68M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Soleno Therapeutics, an estimated $1.4M trimmed.

  • Trellus Management Company's largest Q1 2021 buy was dMY Technology Group, Inc. II: 250,000 shares worth $3.68M.
  • Trellus Management Company added most to Ebix Inc in Q1 2021, an estimated $1.2M increase.
  • Trellus Management Company's biggest Q1 2021 reduction was Soleno Therapeutics, cutting an estimated $1.4M.
  • Trellus Management Company fully exited QuidelOrtho in Q1 2021, selling an estimated $7.15M.
  • Trellus Management Company's ten largest holdings make up 68% of its $193M portfolio in Q1 2021.
  • Trellus Management Company opened 30 new positions and closed 20 in Q1 2021.
  • Trellus Management Company's portfolio value rose 59% quarter-over-quarter to $193M.

Based on Trellus Management Company's 13F filing for Q1 2021, filed 3 May 2021.